We serve Chemical Name:3,5-dibromo-1-benzofuran CAS:99660-97-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,5-dibromo-1-benzofuran
CAS.NO:99660-97-6
Synonyms:dibromo-3,5 benzofuranne;3,5-dibromo-benzofuran;3,5-Dibromobenzo[b]furan;3,5-Dibrom-benzofuran
Molecular Formula:C8H4Br2O
Molecular Weight:275.92500
HS Code:2932999099
Physical and Chemical Properties:
Melting point:77-78ºC
Boiling point:294.9ºC at 760mmHg
Density:1.989g/cm3
Index of Refraction:1.669
PSA:13.14000
Exact Mass:273.86300
LogP:3.95780
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like dibromo-3,5 benzofuranne chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Dibrom-benzofuran physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,dibromo-3,5 benzofuranne Use and application,3,5-dibromo-benzofuran technical grade,usp/ep/jp grade.
Related News: “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. ethyl (E)-2-(3,4-dihydroxystyryl)benzo[d]thiazole-6-carboxylate manufacturers Italian medical packaging firm Stevanato Group went public on the Big Board on July 16, raising $672 million and helping push up the fortune of the billionaire Stevanato family behind the company. L-Phenylalanine, N2-(2-thienylsulfonyl)-L-lysyl-4-bromo- suppliers Walmsley’s background in consumer health—and lack of prior experience in pharma—has reportedly been targeted by Elliott in the investment firm’s secret push for a new boss at GSK. Butylphosphonsaeure-butyl-vinylester vendor & factory “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement.,MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world.
